Cargando…
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539168/ https://www.ncbi.nlm.nih.gov/pubmed/37573403 http://dx.doi.org/10.1038/s41375-023-02004-w |
| _version_ | 1785113439266406400 |
|---|---|
| author | Huber, Sandra Baer, Constance Hutter, Stephan Dicker, Frank Fuhrmann, Irene Meggendorfer, Manja Pohlkamp, Christian Kern, Wolfgang Haferlach, Torsten Haferlach, Claudia Hoermann, Gregor |
| author_facet | Huber, Sandra Baer, Constance Hutter, Stephan Dicker, Frank Fuhrmann, Irene Meggendorfer, Manja Pohlkamp, Christian Kern, Wolfgang Haferlach, Torsten Haferlach, Claudia Hoermann, Gregor |
| author_sort | Huber, Sandra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10539168 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105391682023-09-30 Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC Huber, Sandra Baer, Constance Hutter, Stephan Dicker, Frank Fuhrmann, Irene Meggendorfer, Manja Pohlkamp, Christian Kern, Wolfgang Haferlach, Torsten Haferlach, Claudia Hoermann, Gregor Leukemia Correspondence Nature Publishing Group UK 2023-08-12 2023 /pmc/articles/PMC10539168/ /pubmed/37573403 http://dx.doi.org/10.1038/s41375-023-02004-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Huber, Sandra Baer, Constance Hutter, Stephan Dicker, Frank Fuhrmann, Irene Meggendorfer, Manja Pohlkamp, Christian Kern, Wolfgang Haferlach, Torsten Haferlach, Claudia Hoermann, Gregor Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC |
| title | Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC |
| title_full | Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC |
| title_fullStr | Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC |
| title_full_unstemmed | Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC |
| title_short | Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC |
| title_sort | risk assessment according to ipss-m is superior to aml eln risk classification in mds/aml overlap patients defined by icc |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539168/ https://www.ncbi.nlm.nih.gov/pubmed/37573403 http://dx.doi.org/10.1038/s41375-023-02004-w |
| work_keys_str_mv | AT hubersandra riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc AT baerconstance riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc AT hutterstephan riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc AT dickerfrank riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc AT fuhrmannirene riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc AT meggendorfermanja riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc AT pohlkampchristian riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc AT kernwolfgang riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc AT haferlachtorsten riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc AT haferlachclaudia riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc AT hoermanngregor riskassessmentaccordingtoipssmissuperiortoamlelnriskclassificationinmdsamloverlappatientsdefinedbyicc |